ROS1 kinase inhibitors for molecular-targeted therapies

Medicine and Dentistry

• Phosphotransferase Inhibitor 100%
• Cancer 100%
• Molecularly Targeted Therapy 100%
• Lung Cancer 50%
• Non Small Cell Lung Cancer 50%
• Programmed Cell Death 50%
• Neoplasm 50%
• Signal Transduction 50%
• Phosphotransferase 50%
• Peptide Sequence 50%
• In Vitro 50%
• Cell Migration 50%
• Stomach Adenocarcinoma 50%
• Colorectal Carcinoma 50%
• Plasma Cell Granuloma 50%
• Glioblastoma 50%
• Ovarian Cancer 50%
• Cell Transformation 50%
• Sequence Homology 50%
• Angiosarcoma 50%
• Crizotinib 50%
• Receptor Tyrosine Kinase Like Orphan Receptor 50%

Keyphrases

• Kinase Inhibitor 100%
• Molecular Targeted Therapy 100%
• ROS1 100%
• ROS1 Kinase 100%
• Apoptosis 14%
• Colorectal Cancer 14%
• Tumor 14%
• Signaling Pathway 14%
• Inhibitory Activity 14%
• Ovarian Cancer 14%
• Small Molecules 14%
• Cellular Processes 14%
• Cell Transformation 14%
• Therapeutic Strategies 14%
• Malignancy 14%
• Cell Migration 14%
• Non-small Cell Lung Cancer (NSCLC) 14%
• Human Malignancies 14%
• Gastric Adenocarcinoma 14%
• Receptor Tyrosine Kinase 14%
• Membrane Receptors 14%
• Sequence Homology 14%
• Glioblastoma 14%
• Potential Drugs 14%
• Drug Discovery 14%
• Biological Data 14%
• Angiosarcoma 14%
• Medicinal Chemistry 14%
• Inflammatory Myofibroblastic Tumor 14%
• ROS1 Inhibitor 14%
• Crizotinib 14%
• Rearrangement Technique 14%
• ROS1 Rearrangement 14%
• Scaffold Structure 14%
• ALK Kinase Inhibitors 14%
• ALK-positive Lung Cancer 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Phosphotransferase Inhibitor 100%
• Neoplasm 50%
• Ovary Cancer 50%
• Phosphotransferase 50%
• Cellular Processes 50%
• Non Small Cell Lung Cancer 50%
• Lung Cancer 50%
• Glioblastoma 50%
• Colorectal Carcinoma 50%
• Drug Discovery 50%
• Stomach Adenocarcinoma 50%
• Angiosarcoma 50%
• Pharmaceutical Chemistry 50%
• Crizotinib 50%
• Receptor Tyrosine Kinase Like Orphan Receptor 50%
• Plasma Cell Granuloma 50%